The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
Vitamin B12 is integral to the synthesis of DNA, necessary for cell division and the creation of new cells
For example, a study conducted by Hsieh et al
Frequently Asked Questions Does BPC-157 cause insomnia
Many users report initial changes within a few weeks
Slimtop needs to be taken for more than 2 months to help with weight loss